Patents by Inventor Stefan M. Kammerer

Stefan M. Kammerer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090317816
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: March 9, 2009
    Publication date: December 24, 2009
    Applicant: Sequenom, Inc.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Stefan M. Kammerer, Andreas Braun, Rikard Reneland
  • Publication number: 20090305284
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: June 5, 2009
    Publication date: December 10, 2009
    Applicant: SEQUENOM, INC.
    Inventors: Richard R. Roth, Andreas Braun, Stefan M. Kammerer, Matthew Roberts Nelson, Rikard Henry Reneland, Carolyn R. Hoyal-Wrightson
  • Publication number: 20090258344
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: May 27, 2004
    Publication date: October 15, 2009
    Applicant: SEQUENOM, INC.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Andreas Braun, Stefan M. Kammerer, Mikhail F. Denissenko, Rikard Reneland, Caridad Rosette, Carolyn R. Hoyal-Wrightson
  • Publication number: 20090155846
    Abstract: A-kinase anchor protein (AKAPS) muteins, peptides thereof, and nucleic acids encoding the peptides are provided herein. Also provided are transgenic animals, cells comprising transgenes and various methods employing such peptides.
    Type: Application
    Filed: September 24, 2008
    Publication date: June 18, 2009
    Applicants: SEQUENOM, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Andreas Braun, Charles R. Cantor, Stefan M. Kammerer, Susan Taylor, Lora Burns-Hamuro, Charles Cook, Gary Olson, Christopher Self
  • Patent number: 7510835
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: March 31, 2009
    Assignee: Sequenom, Inc.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Stefan M. Kammerer, Andreas Braun, Rikard Reneland
  • Patent number: 7432342
    Abstract: A-kinase anchor protein (AKAPs) muteins, peptides thereof, and nucleic acids encoding the peptides are provided herein. Also provided are transgenic animals, cells comprising transgenes and various methods employing such peptides.
    Type: Grant
    Filed: May 1, 2003
    Date of Patent: October 7, 2008
    Assignees: Sequenom, Inc., The Regents of the University of Califonia
    Inventors: Andreas Braun, Charles R. Cantor, Stefan M. Kammerer, Susan Taylor, Lora Burns-Hamuro, Charles Cook, Gary Olson, Christopher Self
  • Publication number: 20080199480
    Abstract: Provided herein are methods for identifying a risk of type II diabetes in a subject, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating type II diabetes, and therapeutic and preventative methods applicable to type II diabetes. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: July 22, 2004
    Publication date: August 21, 2008
    Applicant: SEQUENOM, INC.
    Inventors: Maria L. Langdown, Matthew R. Nelson, Rikard H. Reneland, Stefan M. Kammerer, Andreas Braun, Mikhail F. Denissenko, Josephine M. Atienza, Eddine Saiah, James W. Zapf
  • Publication number: 20030232420
    Abstract: A-kinase anchor protein (AKAPs) muteins, peptides thereof, and nucleic acids encoding the peptides are provided herein. Also provided are transgenic animals, cells comprising transgenes and various methods employing such peptides.
    Type: Application
    Filed: May 1, 2003
    Publication date: December 18, 2003
    Inventors: Andreas Braun, Charles R. Cantor, Stefan M. Kammerer, Susan Taylor, Lora Burns-Hamuro, Charles Cook, Gary Olson, Christopher Self